|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Feb 28, 2023
|
FY2022
12 months to Feb 28, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Research and development | |||||
| General and administrative | |||||
| Impairment loss | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Loss on settlement of liabilities | |||||
| Other income | |||||
| Total other income (expense) | |||||
| Net loss | |||||
| Noncontrolling interest | |||||
| Net loss attributable to GenFlat Holdings, Inc. | |||||
| Loss per share - basic and diluted attributable to GenFlat Holdings, Inc. | |||||
| Loss per share - basic and diluted attributable to noncontrolling interest. | |||||
| Weighted average shares outstanding - basic and diluted | |||||
| Loss per share - basic attributable to GenFlat Holdings, Inc | |||||
| Loss per share - diluted attributable to GenFlat Holdings, Inc | |||||
| Loss per share - basic attributable to noncontrolling interest. | |||||
| Loss per share - diluted attributable to noncontrolling interest. | |||||
| Weighted average common shares outstanding - basic | |||||
| Weighted average common shares outstanding - diluted | |||||
Loading...